Literature DB >> 21534686

MRI correlates of cognitive impairment in childhood-onset multiple sclerosis.

C Till1, R Ghassemi, B Aubert-Broche, A Kerbrat, D L Collins, S Narayanan, D L Arnold, M Desrocher, J G Sled, B L Banwell.   

Abstract

OBJECTIVE: Brain MRI measures were correlated with neuropsychological function in 35 pediatric-onset multiple sclerosis (MS) patients and 33 age- and sex-matched healthy controls.
METHOD: Mean age of MS patients was 16.3 ± 2.3 years with average disease duration of 4.3 ± 3.1 years. Cortical gray matter, thalamic, and global brain volumes were calculated for all participants using a scaling factor computed using normalization of atrophy method to normalize total and regional brain volumes for head size. T1- and T2-weighted lesion volumes were calculated for MS patients.
RESULTS: Cognitive impairment (CI) was identified in 29% of the MS cohort. Cognitive deficits predominantly involved attention and processing speed, expressive language, and visuomotor integration. Relative to controls, the MS group showed significantly lower thalamic volume (p < .001), total brain volume (p < .008), and gray matter volume (p < .015). Corpus callosum area and thalamic volume differentiated patients identified as having CI from those without CI (p < .05). Regression models controlling for disease duration and age indicated that thalamic volume accounted for significant incremental variance in predicting global IQ, processing speed, and expressive vocabulary (ΔR2 ranging from .43 to .60) and was the most robust MRI predictor of cognition relative to other MRI metrics.
CONCLUSIONS: The robust association between cognitive function and reduced size of thalamus and global brain volume in pediatric-onset MS patients implicate neurodegenerative processes early in the disease course, and suggest that plasticity of an immature central nervous system is not sufficient to protect patients from the deleterious consequences of MS on cognitive neural networks. (PsycINFO Database Record (c) 2011 APA, all rights reserved).

Entities:  

Mesh:

Year:  2011        PMID: 21534686     DOI: 10.1037/a0022051

Source DB:  PubMed          Journal:  Neuropsychology        ISSN: 0894-4105            Impact factor:   3.295


  36 in total

1.  Connectivity-based parcellation of the thalamus in multiple sclerosis and its implications for cognitive impairment: A multicenter study.

Authors:  Alvino Bisecco; Maria A Rocca; Elisabetta Pagani; Laura Mancini; Christian Enzinger; Antonio Gallo; Hugo Vrenken; Maria Laura Stromillo; Massimiliano Copetti; David L Thomas; Franz Fazekas; Gioacchino Tedeschi; Frederik Barkhof; Nicola De Stefano; Massimo Filippi
Journal:  Hum Brain Mapp       Date:  2015-04-14       Impact factor: 5.038

Review 2.  Therapies for multiple sclerosis: considerations in the pediatric patient.

Authors:  Brenda Banwell; Amit Bar-Or; Gavin Giovannoni; Russell C Dale; Marc Tardieu
Journal:  Nat Rev Neurol       Date:  2011-01-11       Impact factor: 42.937

3.  Affective disorders and Health-Related Quality of Life (HRQoL) in adolescents and young adults with Multiple Sclerosis (MS): the moderating role of resilience.

Authors:  Nunzia Rainone; Alessandro Chiodi; Roberta Lanzillo; Valeria Magri; Anna Napolitano; Vincenzo Brescia Morra; Paolo Valerio; Maria Francesca Freda
Journal:  Qual Life Res       Date:  2016-12-07       Impact factor: 4.147

4.  The computer-based Symbol Digit Modalities Test: establishing age-expected performance in healthy controls and evaluation of pediatric MS patients.

Authors:  Sandra Bigi; R A Marrie; C Till; E A Yeh; N Akbar; A Feinstein; B L Banwell
Journal:  Neurol Sci       Date:  2017-01-11       Impact factor: 3.307

Review 5.  Multiple sclerosis in children: an update on clinical diagnosis, therapeutic strategies, and research.

Authors:  Amy Waldman; Angelo Ghezzi; Amit Bar-Or; Yann Mikaeloff; Marc Tardieu; Brenda Banwell
Journal:  Lancet Neurol       Date:  2014-09       Impact factor: 44.182

6.  Attitudes, perceptions, and use of marijuana in youth with multiple sclerosis.

Authors:  J Nicholas Brenton; Teri Schreiner; Krystle Karoscik; Meg Richter; Samantha Ferrante; Amy Waldman; Brenda Banwell
Journal:  J Neurol       Date:  2017-12-22       Impact factor: 4.849

Review 7.  Future Brain and Spinal Cord Volumetric Imaging in the Clinic for Monitoring Treatment Response in MS.

Authors:  Tim Sinnecker; Cristina Granziera; Jens Wuerfel; Regina Schlaeger
Journal:  Curr Treat Options Neurol       Date:  2018-04-20       Impact factor: 3.598

8.  Acquisition of Early Developmental Milestones and Need for Special Education Services in Pediatric Multiple Sclerosis.

Authors:  Gregory Aaen; Michael Waltz; Wendy Vargas; Naila Makhani; Jayne Ness; Yolanda Harris; T Charles Casper; Leslie Benson; Meghan Candee; Tanuja Chitnis; Mark Gorman; Jennifer Graves; Benjamin Greenberg; Timothy Lotze; Soe Mar; Jan-Mendelt Tillema; Mary Rensel; Moses Rodriguez; John Rose; Jennifer Rubin; Teri Schreiner; Amy Waldman; Bianca Weinstock-Guttman; Anita Belman; Emmanuelle Waubant; Lauren Krupp
Journal:  J Child Neurol       Date:  2018-12-17       Impact factor: 1.987

9.  The educational impact of childhood-onset multiple sclerosis: Why assessing academic achievement is imperative.

Authors:  W S Vargas; K G Noble; B Banwell; P De Jager
Journal:  Mult Scler       Date:  2020-05-28       Impact factor: 6.312

10.  Cognitive impairment occurs in children and adolescents with multiple sclerosis: results from a United States network.

Authors:  Laura Julian; Dana Serafin; Leigh Charvet; Joseph Ackerson; Ralph Benedict; Ellen Braaten; Tanya Brown; Ellen O'Donnell; Joy Parrish; Thomas Preston; Michael Zaccariello; Anita Belman; Tanuja Chitnis; Mark Gorman; Jayne Ness; Marc Patterson; Moses Rodriguez; Emmanuelle Waubant; Bianca Weinstock-Guttman; Ann Yeh; Lauren B Krupp
Journal:  J Child Neurol       Date:  2012-11-15       Impact factor: 1.987

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.